AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

HIKMA Pharmaceuticals PLC

Director's Dealing Aug 10, 2023

4841_dirs_2023-08-10_152d9c93-eb48-4b67-8269-183bed4b071d.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 9923I

Hikma Pharmaceuticals Plc

10 August 2023

Notification and public disclosure of transactions by persons discharging managerial responsibilities

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Bassam Kanaan
2 Reason for the notification
a) Position/status PDMR
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification code Description: Ordinary shares of 10 pence each (Shares)

ID Code: GB00B0LCW083
b) Nature of the transaction Disposal of 25,000 of ordinary shares at 10 pence each in Hikma Pharmaceuticals PLC
c) Price(s) and volume(s) Price(s): £21.71

Volume(s):25,000
d) Aggregated information

-       Volume



-       Price

-       Total
25,000

 £21.71

 £542,750
e) Date of the transaction 08 August 2023
f) Place of the transaction London Stock Exchange (XLON)
1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Brian Hoffmann
2 Reason for the notification
a) Position/status PDMR
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification code Description: Ordinary shares of 10 pence each (Shares)

ID Code: GB00B0LCW083
b) Nature of the transaction Disposal of 5,912 ordinary shares at 10 pence each in Hikma Pharmaceuticals PLC.
c) Price(s) and volume(s) Price(s): £22.05

Volume(s):5,912
d) Aggregated information

-       Volume



-       Price

-       Total
5,912

 £22.05

 £130,359.60
e) Date of the transaction 09 August 2023
f) Place of the transaction London Stock Exchange (XLON)

Helen Middlemist, Deputy Company Secretary

+44 (0) 20 7399 2760

10 August 2023

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBUGDIDUBDGXG

Talk to a Data Expert

Have a question? We'll get back to you promptly.